GlassScriptPhysician profile
Jason Wilson
NPI 1235132531
$2,595.91
in general payments reported to CMS, 2019-2025
29 companies · $463 in 2025
The $463 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $276 · 2021: $354 · 2022: $344 · 2023: $222 · 2024: $421 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $364.15 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $340.23 | 2022-2025 | Veozah |
| Amgen INC. | $300.82 | 2019-2022 | |
| Pfizer INC. | $230.22 | 2019-2023 | |
| Daiichi Sankyo INC. | $140.35 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $139.76 | 2022-2024 | |
| Medtronic, INC. | $124.02 | 2021 | |
| Hologic Sales and Service, LLC | $105.40 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Omni Hysteroscope |
| Evofem Biosciences, INC. | $101.24 | 2021-2025 | Phexxi, Solosec, Phexx |
| Avion Pharmaceuticals | $100.78 | 2019-2023 | Balcoltra |
| Dexcom, INC. | $97.01 | 2025 | Dexcom G6 Transmitter |
| Lupin INC. | $83.31 | 2019-2021 | |
| Sage Therapeutics, LLC | $62.58 | 2024-2025 | Zurzuvae |
| Organon LLC | $56.19 | 2022-2025 | Jada System |
| Shield Therapeutics INC | $56.18 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $51.32 | 2025 | Wegovy |
| Roche Diagnostics Corporation | $38.66 | 2019 | |
| Smith+Nephew, INC. | $31.56 | 2024 | Pico 14, Renasys Touch, Pico 7 |
| Coopersurgical, INC. | $21.11 | 2019 | |
| Minerva Surgical, INC | $20.04 | 2022 | |
| Exeltis, USA INC. | $17.52 | 2024 | Slynd |
| Exact Sciences Corporation | $16.17 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $14.85 | 2023 | Gardasil 9 |
| Amag Pharmaceuticals, INC. | $14.85 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.83 | 2020 | |
| Lilly USA, LLC | $14.57 | 2023 | Zepbound |
| Therapeuticsmd, INC. | $14.41 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.09 | 2020 | |
| Aspira Women'S Health INC | $9.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.